Enovis (ENOV) Total Current Liabilities (2010 - 2026)
Enovis' (ENOV) quarterly Total Current Liabilities came in at $612.1 million in Q3 2026, up 7.72% year-over-year from $568.2 million in Q3 2025, and up 0.56% quarter-over-quarter from $608.7 million in Q2 2026.
Analysis
Enovis (ENOV) Total Current Liabilities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Total Current Liabilities for 17 consecutive years, with $612.1 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Total Current Liabilities rose 7.72% year-over-year to $612.1 million in Q3 2026; TTM through Jul 2026 was $612.1 million, a 7.72% increase from a year earlier, with the FY2025 full-year figure at $598.5 million, up 13.13% from the prior year.
- Total Current Liabilities was $612.1 million for Q3 2026 at Enovis, up from $608.7 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $1.5 billion in Q2 2022 and troughed at $349.5 million in Q1 2023.
- A 5-year average of $593.1 million and a median of $557.2 million in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities plunged 75.9% in 2023 and jumped 57.12% in 2024, its largest moves.
- Over 5 years, Total Current Liabilities stood at $565.2 million in 2022, then tumbled by 34.61% to $369.6 million in 2023, then soared by 43.12% to $529.0 million in 2024, then gained by 13.13% to $598.5 million in 2025, then rose by 2.27% to $612.1 million in 2026.
- The last three Total Current Liabilities figures came in at $612.1 million (Q3 2026), $608.7 million (Q2 2026), and $598.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.55 Bn | 175.95 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 127.61 Bn | 122.40 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.18 Bn | 108.37 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 105.17 Bn | 101.69 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 64.67 Bn | 64.13 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | 612.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 612.05 Mn |
| Apr 3, 2026 | 608.67 Mn |
| Dec 31, 2025 | 598.47 Mn |
| Oct 3, 2025 | 575.44 Mn |
| Jul 4, 2025 | 568.18 Mn |
| Apr 4, 2025 | 477.42 Mn |
| Dec 31, 2024 | 529.00 Mn |
| Sep 27, 2024 | 530.22 Mn |
| Jun 28, 2024 | 518.01 Mn |
| Mar 29, 2024 | 549.13 Mn |
| Dec 31, 2023 | 369.61 Mn |
| Sep 29, 2023 | 355.28 Mn |
| Jun 30, 2023 | 353.67 Mn |
| Mar 31, 2023 | 349.50 Mn |
| Dec 31, 2022 | 565.20 Mn |
| Sep 30, 2022 | 853.92 Mn |
| Jul 1, 2022 | 812.80 Mn |
| Apr 1, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.02 Bn |
| Oct 1, 2021 | 975.47 Mn |